FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

39304011000001102: Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Feb 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71391000001110 Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
71401000001113 Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) Has specific active ingredient Pertuzumab true Inferred relationship Existential restriction modifier
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) Is a Pertuzumab 1.2g/15ml / Trastuzumab 600mg/15ml solution for injection vials true Inferred relationship Existential restriction modifier
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) Is a Phesgo true Inferred relationship Existential restriction modifier
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) Has specific active ingredient Trastuzumab true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) 1 vial Has AMP True Phesgo 1200mg/600mg/15ml solution for injection vials (Roche Products Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start